Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.6 USD | +2.99% | +1.18% | +56.93% |
Apr. 18 | ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing | MT |
Apr. 18 | ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.93% | 809M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- SPRY Stock
- News ARS Pharmaceuticals, Inc.
- ARS Pharmaceuticals Files Response to FDA Complete Response Letter For Neffy